Global Blood Screening Market

Global Blood Screening Market Size, Share, Growth Analysis, By Product Type(Reagents & Kits, Instruments), By End User(Hospitals & Clinics, Blood Banks) - Industry Forecast 2024-2031


Report ID: SQMIG35J2044 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 64 | Figures: 77

Global Blood Screening Market Insights

Global Blood Screening Market size was valued at USD 2.73 Billion in 2022 and is poised to grow from USD 2.96 Billion in 2023 to USD 5.69 Billion by 2031, at a CAGR of 8.50% during the forecast period (2024-2031).

Automated molecular platforms for blood screening have been a popular tactic among top industry participants, which is helping the market grow. A few of the key reasons boosting the growth of the blood screening market are the rising number of blood donations and blood donors, increased awareness of the safety of donated blood, rising prevalence of infectious illnesses, and a number of government initiatives. Rising blood donations, an increase in the prevalence of infectious diseases, and government initiatives are all contributing to the market's explosive growth. Over 234 million major surgeries are carried out annually worldwide, according to the article titled "Operative Risk" that was published in December 2021. To prepare for childhood acute anaemia, trauma, and congenital maternal blood abnormalities, blood transfusions are frequently administered in problematic childbirths. Moreover, the World Health Organization (WHO) Factsheet from June 2021 states that 118.5 million blood donations are made worldwide, with 40% of those donations made in high-income countries, which account for 16% of global blood donations. In high-income countries, 31.5% of donations are made up of blood, compared to 15.9% in upper-middle-income nations, 6.8% in lower-middle-income nations, and 5.0% in low-income nations.

US Blood Screening Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Blood Screening Market size was valued at USD 2.73 Billion in 2022 and is poised to grow from USD 2.96 Billion in 2023 to USD 5.69 Billion by 2031, at a CAGR of 8.50% during the forecast period (2024-2031).

The competitive landscape of the blood screening market includes information by competitor. The company's financials, revenue generated, market potential, investment in R&D, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width Details like depth, breadth, and application dominance are also presented. The data presented here only refers to blood screening as a market emphasis for the companies. 'Abbott Laboratories (USA)', 'Becton, Dickinson and Company (USA)', 'Bio-Rad Laboratories, Inc. (USA)', 'bioMérieux SA (France)', 'F. Hoffmann-La Roche Ltd. (Switzerland)', 'Grifols, S.A. (Spain)', 'Hologic, Inc. (USA)', 'Immucor, Inc. (USA)', 'Meridian Bioscience, Inc. (USA)', 'Ortho Clinical Diagnostics (USA)', 'Quotient Limited (UK)', 'Siemens Healthineers AG (Germany)', 'Sysmex Corporation (Japan)', 'Thermo Fisher Scientific Inc. (USA)', 'Danaher Corporation (USA)', 'Grifols Diagnostic Solutions Inc. (USA)', 'Haemonetics Corporation (USA)', 'Luminex Corporation (USA)', 'Natera, Inc. (USA)', 'Novartis International AG (Switzerland)', 'PerkinElmer, Inc. (USA)', 'Promega Corporation (USA)'

There is a growing awareness among healthcare professionals and patients about the risks associated with blood transfusions, such as the transmission of infectious diseases. This is leading to an increased demand for blood screening products that can ensure the safety of blood and blood products.

The demand for plasma-derived products, such as immunoglobulins and clotting factors, is growing, and this is driving the demand for blood screening products that can ensure the safety of these products. This trend is expected to continue as the use of plasma-derived products expands into new therapeutic areas.

A growing prevalence of renal, heart, and bacterial diseases in nations like India and China is predicted to cause the Asia Pacific market to represent the greatest revenue share in the global market during the projection period. In India, chronic kidney disease affects more than 7.8 million people. In addition to these factors, the market revenue growth is being fueled by increased government and corporate efforts to increase public knowledge and confidence. A rise in cardiovascular diseases and changes in lifestyle are two other elements influencing the market's revenue growth. The largest population of diabetic patients worldwide, at over 141 million, is found in China.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Blood Screening Market

Product ID: SQMIG35J2044

$5,300
BUY NOW GET FREE SAMPLE